| The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell–and antibody‐mediated rejection A Loupy, M Haas, C Roufosse, M Naesens, B Adam, M Afrouzian, ... American Journal of Transplantation 20 (9), 2318-2331, 2020 | 593 | 2020 |
| A randomized trial of bortezomib in late antibody-mediated kidney transplant rejection F Eskandary, H Regele, L Baumann, G Bond, N Kozakowski, ... Journal of the American Society of Nephrology 29 (2), 591-605, 2018 | 269 | 2018 |
| Renal elimination of sclerostin increases with declining kidney function D Cejka, R Marculescu, N Kozakowski, M Plischke, T Reiter, A Gessl, ... The Journal of Clinical Endocrinology & Metabolism 99 (1), 248-255, 2014 | 165 | 2014 |
| A randomized clinical trial of anti–IL-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection K Doberer, M Duerr, PF Halloran, F Eskandary, K Budde, H Regele, ... Journal of the American Society of Nephrology 32 (3), 708-722, 2021 | 131 | 2021 |
| Torque Teno virus load—inverse association with antibody-mediated rejection after kidney transplantation M Schiemann, E Puchhammer-Stöckl, F Eskandary, P Kohlbeck, ... Transplantation 101 (2), 360-367, 2017 | 103 | 2017 |
| Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection E Schwaiger, F Eskandary, N Kozakowski, G Bond, Ž Kikić, D Yoo, ... Nephrology Dialysis Transplantation 31 (8), 1342-1351, 2016 | 81 | 2016 |
| Diagnostic contribution of donor-specific antibody characteristics to uncover late silent antibody-mediated rejection—results of a cross-sectional screening study F Eskandary, G Bond, N Kozakowski, H Regele, L Marinova, ... Transplantation 101 (3), 631-641, 2017 | 75 | 2017 |
| Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection—results from a first-in-patient phase 1 trial F Eskandary, B Jilma, J Mühlbacher, M Wahrmann, H Regele, ... American Journal of Transplantation 18 (4), 916-926, 2018 | 71 | 2018 |
| NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosis W Eilenberg, S Stojkovic, A Kaider, N Kozakowski, CM Domenig, ... Clinical Chemistry and Laboratory Medicine (CCLM) 56 (1), 147-156, 2017 | 63 | 2017 |
| Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment W Eilenberg, S Stojkovic, A Piechota-Polanczyk, A Kaider, N Kozakowski, ... Cardiovascular Diabetology 16, 1-11, 2017 | 52 | 2017 |
| Capillary C4d and kidney allograft outcome in relation to morphologic lesions suggestive of antibody-mediated rejection Ž Kikić, A Kainz, N Kozakowski, R Oberbauer, H Regele, G Bond, ... Clinical Journal of the American Society of Nephrology 10 (8), 1435-1443, 2015 | 46 | 2015 |
| Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model W Poeppl, S Tobudic, T Lingscheid, R Plasenzotti, N Kozakowski, ... Antimicrobial agents and chemotherapy 55 (11), 4999-5003, 2011 | 46 | 2011 |
| Persistent inflammation leads to proliferative neoplasia and loss of smooth muscle cells in a prostate tumor model A Birbach, D Eisenbarth, N Kozakowski, E Ladenhauf, ... Neoplasia 13 (8), 692-IN17, 2011 | 45 | 2011 |
| The Banff 2022 Kidney Meeting Report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics M Naesens, C Roufosse, M Haas, C Lefaucheur, RB Mannon, BA Adam, ... American Journal of Transplantation 24 (3), 338-349, 2024 | 43 | 2024 |
| Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation ML Arnold, A Kainz, LG Hidalgo, F Eskandary, N Kozakowski, ... American Journal of Transplantation 18 (9), 2261-2273, 2018 | 40 | 2018 |
| MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus H Leiss, W Salzberger, B Jacobs, I Gessl, N Kozakowski, S Blüml, ... PLoS One 12 (7), e0181015, 2017 | 37 | 2017 |
| The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss N Kozakowski, H Herkner, GA Böhmig, H Regele, C Kornauth, G Bond, ... Kidney International 88 (2), 332-340, 2015 | 36 | 2015 |
| Biopsy diagnostics in renal allograft rejection: from histomorphology to biological function N Kozakowski, H Regele Transplant International 22 (10), 945-953, 2009 | 36 | 2009 |
| Quantitative PCR of INDEL s to measure donor‐derived cell‐free DNA—a potential method to detect acute rejection in kidney transplantation: a pilot study EM Dauber, D Kollmann, N Kozakowski, S Rasoul‐Rockenschaub, ... Transplant International 33 (3), 298-309, 2020 | 35 | 2020 |
| Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats W Poeppl, T Lingscheid, D Bernitzky, UY Schwarze, O Donath, ... Antimicrobial agents and chemotherapy 58 (9), 5111-5116, 2014 | 32 | 2014 |
